HAYA Therapeutics is a biopharmaceutical company that specializes in treating heart failure diseases.
haya therapeutics has raised €58M across 2 funding rounds from 12 investors, most recently a Series A round in May 2025. Based in Lausanne, Switzerland; founded 2019; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2025-05-08 | Series A | €58M | +ND Capital,4see Ventures,Alexandria Venture Investments,Apollo Health Ventures,ATHOS CAPITAL,Bernina BioInvest+6 more | View deal → |
| 2019-10-01 | Other | €92k | — | View deal → |
